Blood test breakthrough could spot sepsis danger early

NCT ID NCT02545478

Recruiting now Knowledge-focused Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Apr 16, 2026 · Last updated May 21, 2026 · Updated 5 times

Summary

This study is looking at whether early signs in the blood can help doctors identify which patients with infections are at risk for serious complications like sepsis. Researchers will follow 4,200 adults to see how well these early markers predict death and organ failure within 28 days. The goal is to improve early detection and treatment for those most at risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Massachusetts General Hospital
ACTIVE_NOT_RECRUITING

Boston, Massachusetts, 02114, United States

Conditions

Explore the condition pages connected to this study.

INFECTION INFLAMMATION SEPSIS